FDA approves Roche's Polivy for untreated diffuse large B-cell lymphoma

Polivy combination is the first FDA-approved therapy in nearly 20 years for the first-line treatment of diffuse large B-cell lymphoma, an aggressive dise...

April 20, 2023 | Thursday | News
Study: Drug May Delay Earliest Symptoms of Multiple Sclerosis

The preliminary study, released April 19, 2023, will be presented at the American Academy of Neurology's 75th Annual Meeting, being held in person in Bosto...

April 20, 2023 | Thursday | News
JACS Solutions and Baicells to Unveil End-to-End Private 5G Solutions for the Healthcare Industry

Baicells Technologies, a global provider of LTE and 5G network solutions, and JACS Solutions, a global provider of custom connectivity solutions for indust...

April 20, 2023 | Thursday | News
Segmed, NVIDIA, and RadImageNet Kickstart Generative AI Initiative for Synthetic Medical Imaging Data

As part of this initiative, Segmed will offer synthetic medical imaging data on their self-serve medical data curation platform, Segmed Insight. This is in...

April 20, 2023 | Thursday | News
Menarini announces exclusive distribution agreement for Boditech's AFIAS-10 system

A.Menarini Diagnostics S.r.l. (Menarini) is pleased to announce an exclusive distribution agreement for the AFIAS-10 System and IGRA-TB Assay (among others...

April 20, 2023 | Thursday | News
PANTHERx® Rare Announces Release of CUVRIOR™ to Treat Wilson Disease

"We are pleased to add CUVRIOR to the list of PANTHERx® medications. The PANTHERx team works hard to make a positive difference in the lives of ou...

April 20, 2023 | Thursday | News
Takeda Showcases Digital Health Solutions at G20 Meeting in India

Takeda Biopharmaceuticals India Private Limited Showcased Digital Innovations- MyPKFit, SYNAPSE and Athena at the G20 Health Working Group Meeting ·...

April 19, 2023 | Wednesday | News
Revive Therapeutics Provides Update of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19

Announced an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) (NCT045...

April 19, 2023 | Wednesday | News
Scientists Discover Key Role of Glucose in Brain Activity

The human brain has a sweet tooth, burning through nearly one quarter of the body's sugar energy, or glucose, each day. Now, researchers at Gladstone Insti...

April 19, 2023 | Wednesday | News
Cultivarium Announces Collaboration with ATCC to Expand Repertoire of Microbes Available for the Bioeconomy

The collaboration seeks to expand the utility of ATCC's microbiology reference materials to accelerate biomanufacturing and biotechnology research and deve...

April 19, 2023 | Wednesday | News
Cytiva's X-Platform Bioreactors Boost Process Efficiency, Paving the Way for Future Biomanufacturing Breakthroughs

Global biotechnology leader builds on Xcellerex heritage to now offer X-platform bioreactors. X-platform bioreactors can be used for monoclonal antibodi...

April 19, 2023 | Wednesday | News
FDA Authorizes Changes to Simplify Use of Bivalent mRNA COVID-19 Vaccines

What You Need to Know: Most individuals, depending on age, previously vaccinated with a monovalent COVID-19 vaccine who have not yet received a dose of ...

April 19, 2023 | Wednesday | Regulatory
FDA Approves Cell Therapy for Patients with Blood Cancers to Reduce Risk of Infection Following Stem Cell Transplantation

"Today's approval is an important advance in cell therapy treatment in patients with blood cancers," said Peter Marks, M.D., Ph.D., director of the FDA's C...

April 18, 2023 | Tuesday | News
Xyall and Indica Labs collaborate to transform precision oncology workflows

Bridging the gap between histopathology and molecular pathology Xyall and Indica Labs have entered into a global strategic partnership designed to bridge ...

April 18, 2023 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close